Physiologically-based Pharmacokinetics in Drug Development and Regulatory Science Publication Physiologically-based Pharmacokinetics in Drug Development and Regulatory Science The application of physiologically-based pharmacokinetic (PBPK) modeling is coming of age in drug development and…Danielle Pillsbury2011年2月1日
PBPK Modeling of Inter-individual Variability in the Pharmacokinetics of Environmental Chemicals Publication PBPK Modeling of Inter-individual Variability in the Pharmacokinetics of Environmental Chemicals Generic PBPK models, applicable to a large number of substances, coupled to parameter databases and…Danielle Pillsbury2010年12月30日
Physiologically-based Mechanistic Modeling to Predict Complex Drug–drug Interactions Involving Simultaneous Competitive and Time-dependent Enzyme Inhibition by Parent Compound and Its Metabolite in Both Liver and Gut—The Effect of Diltiazem on the Time-course of Exposure to Triazolam Publication Physiologically-based Mechanistic Modeling to Predict Complex Drug–drug Interactions Involving Simultaneous Competitive and Time-dependent Enzyme Inhibition by Parent Compound and Its Metabolite in Both Liver and Gut—The Effect of Diltiazem on the Time-course of Exposure to Triazolam The aim of this study was to predict the magnitude of metabolic drug-drug interaction (mDDI)…Danielle Pillsbury2010年3月18日
Physiologically-based Pharmacokinetics (PBPK) Publication Physiologically-based Pharmacokinetics (PBPK) Allometric scaling is widely used to predict human pharmacokinetic parameters from preclinical species, and many…Danielle Pillsbury2009年6月1日
Pharmacokinetic Predictions in Children by Using the Physiologically-based Pharmacokinetic Modeling Publication Pharmacokinetic Predictions in Children by Using the Physiologically-based Pharmacokinetic Modeling Nowadays, 50-90% of drugs used in children have never been actually studied in this population. Consequently, either…Danielle Pillsbury2008年12月1日
The Effects of CYP3A4 Inhibition on Erlotinib Pharmacokinetics: Computer-based Simulation (Simcyp) Predicts In Vivo Metabolic Inhibition Publication The Effects of CYP3A4 Inhibition on Erlotinib Pharmacokinetics: Computer-based Simulation (Simcyp) Predicts In Vivo Metabolic Inhibition BACKGROUND: Erlotinib is an orally active antitumor agent. Analyses in vitro using human liver microsomes and…Danielle Pillsbury2008年1月1日
Physiologically-based Approaches Towards the Prediction of Pharmacokinetics: In Vitro-In Vivo Extrapolation Publication Physiologically-based Approaches Towards the Prediction of Pharmacokinetics: In Vitro-In Vivo Extrapolation In adapting to the challenge to make more informed selection of compounds for development, the…Danielle Pillsbury2007年12月1日